2025 Automated Compounding Devices Industry Trends Report: Long-Term Outlook Through 2034

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Automated Compounding Devices Market Size By 2025?
In the last few years, the market size for automated compounding devices has seen significant growth. It's projected to rise from $2.36 billion in 2024 to $2.53 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. Factors contributing to the observed growth during the historical period include an increase in chronic disease cases, an aging demographic, advancement in healthcare infrastructure, legislative demands, and a rise in medication mistakes.

How Big Is the Automated Compounding Devices Market Size Expected to Grow by 2029?
Expectations are high for substantial growth in the automated compounding devices market over the coming years, with a projected increase to $3.34 billion by 2029 and a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during this period is attributable to factors such as increased cancer rates, expanded global healthcare, heightened attention to patient safety, regulatory backing, and a growing emphasis on sustainability. Key trends expected during this period include telemedicine, remote healthcare services, improvements in artificial intelligence, digitalization in healthcare, and real-time monitoring.

View the full report here:
https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

Which Key Market Drivers Powering Automated Compounding Devices Market Expansion and Growth?
As personalized medicines grow in quantity, it is predicted that the automated compounding devices market will also expand. Personalized medicine encompasses a medical method that modifies healthcare decisions, procedures, interventions, and cures to match each patient's unique characteristics. The surge in personalized medicines results from improved knowledge of genetics, specific patient data, and regulatory assistance. Automated compounding devices (ACDs) are instrumental in personalized medicine as they facilitate the exact and precise creation of customized medication formulations specific to each patient's requirements. These devices expedite the blending of various pharmaceutical ingredients in certain proportions, crucial in developing personalized therapies. As an illustration, the Personalized Medicine Coalition, an American non-profit organization, reported in February 2024, that the FDA approved 16 unique personalized therapies for patients with rare diseases in 2023, a notable increase from six in 2022. Consequently, the rising quantity of personalized medicines fuels the growth of the automated compounding devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Automated Compounding Devices Market?
Leading firms in the automated compounding device market are concentrating their efforts on minimizing medication mistakes and improving patient safety by implementing innovative technologies, like robotic compounding technology. This focus aims to gain customer trust, ensure regulatory compliance, and secure a competitive edge. The robotic compounding technology revolutionizes the precise development and blending of medical compounds using high-tech robotic systems, improving precision, productivity, and safety during medication preparation. For example, in March 2022, Omnicell Inc., a healthcare technology firm based in the US, introduced the IVX Station, a state-of-the-art automated compounding device. This cutting-edge solution is designed to broaden the availability of IV robotic technology in a wider market, improving patient safety, precision, cost effectiveness, supply chain organization, and compliance with regulations. The IVX Station provides a processing speed three times quicker than existing IV robotic systems, features a robust design to reduce downtime, and has a small form factor ideal for pharmacy environments.

What Are the Emerging Segments in the Automated Compounding Devices Market?
The automated compounding devices market covered in this report is segmented -

1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software
2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems
3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)
2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18231&type=smp

Who Are the Global Leaders in the Automated Compounding Devices Market?
Major companies operating in the automated compounding devices market are McKesson Corporation, Amerisource Bergen Corporation, Medtronic PLC, Becton Dickinson and Company, Baxter International Inc, B. Braun Melsungen AG, Fresenius Kabi AG, Grifols International S.A., Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Cantel Medical Corp., Fagron N.V., Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group S.p.A., ARxIUM Inc., Codonics Inc., Apexus Inc., Equashield LLC, Yuyama Mfg Co. Ltd., Shanghai Weibond Technology Co. Ltd., Quirem Medical B.V

Which are the Top Profitable Regional Markets for the Automated Compounding Devices Industry?
North America was the largest region in the automated compounding devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18231

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Contact Us:
The Business Research Company
Europe: +44 7882 955267
Asia: +91 88972 63534
Americas: +1 310-496-7795
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.